Home
Sanofi SNY paid Forbes-Tate $50K for lobbying in Q3 2024 · Health Issues, Medicare and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q3 2024
- Stock
- Sanofi SNY
- Client
- Sanofi U.S.
- Reported
- 24/10/17
Up 0.0% from last quarter
What else happened in Sanofi around then
Filed or reported within 30 days of the trade day · 24/08/31~24/10/30Sanofi U.S.'s other lobbying reports
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 07/20
for Q2
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 07/20
for Q2
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 04/20
for Q1
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 04/19
for Q1
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 01/20
for Q4 2025